Barclays raised the firm’s price target on Becton Dickinson (BDX) to $279 from $278 and keeps an Overweight rating on the shares. The firm says its updated sum-of-the-parts valuation analysis suggests 19% upside to Becton from current levels, based on an updated model estimates and several changes to assumptions.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BDX:
- Becton Dickinson director buys $350.4K in common stock
- Becton Dickinson: Undervalued Growth Opportunity with Strategic Options for Shareholder Value Enhancement
- Becton, Dickinson’s Strong Q1 Amidst Global Challenges
- Becton Dickinson price target lowered to $270 from $275 at Wells Fargo
- Becton Dickinson’s Strategic Diagnostics Separation Fuels Positive Outlook for MedTech Growth